Healthy Skepticism Library item: 5901

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Durbin RL.
Appetite stimulant claim deleted from label—response
Canadian Family Physician 1994; 40:22

Abstract:

Merck is deleting the indication for appetite stimulation from the labeling of Periactin (cyproheptadine) although Merck continues to believe that this use of the drug is supported by a substantial body of evidence.

Keywords:
*letter to the editor/Canada/developed countries/Merck/Periactin/cyproheptadine/quality of information/ appetite stimulants and suppressants/company responses/ETHICAL ISSUES IN PROMOTION: COMPANY STANDARDS/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: WEIGHT GAIN AND LOSS